On rare occasions, LRRK2 mutations may be present in progressive supranuclear palsy or atypical parkinsonian patients (Sanchez-Contreras et al., 2017; Vilas et al., 2018); however, we did not identify any pathogenic mutations in these patients. This evidence concerns the gene LRRK2 and progressive supranuclear palsy.